PQ 479
479. Deputy Michael Murphy asked the Minister for Health to clarify proposals to review prescribing practices as part of measures to control expenditure on medicines; whether any such measures could restrict the ability of a treating consultant or other medical practitioner to prescribe the medicine they consider clinically appropriate for an individual patient; the role cost considerations will have in decisions concerning high-cost and high-tech medicines; and if she will confirm that clinical decisions regarding an individual patient’s treatment will remain a matter for appropriately qualified clinicians. [69592/26]
Introduced
1 October 2026
Last action
1 October 2026 · Medicinal Products
Status
written
Sponsors
Michael Murphy
Subjects
Discovery layer
Source updated
1 October 2026
Summary
479. Deputy Michael Murphy asked the Minister for Health to clarify proposals to review prescribing practices as part of measures to control expenditure on medicines; whether any such measures could restrict the ability of a treating consultant or other medical practitioner to prescribe the medicine they consider clinically appropriate for an individual patient; the role cost considerations will have in decisions concerning high-cost and high-tech medicines; and if she will confirm that clinical decisions regarding an individual patient’s treatment will remain a matter for appropriately qualified clinicians. [69592/26]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
1 October 2026
Medicinal Products
479. Deputy Michael Murphy asked the Minister for Health to clarify proposals to review prescribing practices as part of measures to control expenditure on medicines; whether any such measures could restrict the ability of a treating consultant or other medical practitioner to prescribe the medicine they consider clinically appropriate for an individual patient; the role cost considerations will have in decisions concerning high-cost and high-tech medicines; and if she will confirm that clinical decisions regarding an individual patient’s treatment will remain a matter for appropriately qualified clinicians. [69592/26]
Source: written
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Medicinal Products
xml · EN · 1 October 2026
Sponsors
- Michael Murphy · Asking member
- Health · Health · Addressed to
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2026-10-01/479/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2026-10-01/pq_479
- ireland · q-2026-10-01-pq_479 · source updated 1 October 2026